Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06059547 |
|---|---|
| Brief Title: | Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer |
| First Submitted : | August 23, 2023 |
| First Submitted that Met QC Criteria : | September 21, 2023 |
| First Posted : | September 28, 2023 |
| Last Update Submitted that Met QC Criteria : | September 21, 2023 |
| Last Update Posted : | September 28, 2023 |